Kisoji Biotechnologie Inc.
$350,000.00 CAD
≈ 5 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- November 1, 2018 – November 1, 2019
- Reference
- nrc-cnrc:172-2018-2019-Q3-916018
Published purpose
Cancer remains a very important disease in North America and the world. Antibodies have emerged as an effective treatment for cancer. KisoJi is developing antibodies for treatment of newly diagnosed cancers and for previously treated cancers.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions